Connect your AI

ADMA Biologics ADMA Plasma Collection Centers — Gain On Sale Of Investments

Other segment segments

ADMA Bio Manufacturing

$0—

Similar metrics at other companies

STWDCommercial and Residential Lending Segment — Gain on sale of investments and other assets, net

$210K—

TERGain (Loss) on Sale of Investments

-$3.32M+1.6%

NXPIGain (Loss) on Sale of Investments

$1M+117%

STWDInvesting and Servicing Segment — Gain on sale of investments and other assets, net

$0—

STWDGain on Sale of Investments Cash Flow

$679K—

CASHCorporate Services/Other — Gain on sale of other

$0—

Other financials

Income statement

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

Market cap$2.02B-54.5%

Profitability

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:GainOnSaleOfInvestments.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's plasma collection centers — gain on sale of investments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ADMA Biologics's plasma collection centers — gain on sale of investments?: ADMA Biologics (ADMA) reported plasma collection centers — gain on sale of investments of $7.98M in Q1 2026.
What does plasma collection centers — gain on sale of investments mean?: Represents the realized profit from the disposal of assets or financial investments held by the plasma collection segment. This is a non-recurring item that can distort the view of core operational profitability. Investors monitor this to separate operational performance from capital management activities.